Who is impact biomedical?

Impact Biomedical Inc. is a subsidiary of DSS, Inc (“DSS”: NYSE). IBIO discovers, confirms, and patents unique science and technologies which can be developed into new offerings in human healthcare and wellness in collaboration with external partners through licensing, co-development, joint ventures, and other relationships.

Who owns impact biomedical?

HENRIETTA, N.Y., June 28, 2022 (GLOBE NEWSWIRE) -- Impact Biomedical, Inc., a wholly owned subsidiary of DSS, Inc. (NYSE American: DSS), along with its scientific research partner Global Research and ... China is one of the leading markets globally for insect repellants China is one of the leading markets globally for insect repellants

How many shares of Impact Biomedical Inc will DSS receive?

DSS Shareholders of Record on July 10, 2023 to Receive Four Shares of Impact Biomedical Inc. for Every One Share of DSS, Inc. DSS Shareholders of Record on July 10, 2023 to Receive Four Shares of Impa...